INTRODUCTION
The observational study published in this issue of IJCIIS Power et al., compared the reliability and effective usability of FloTrac ™ /Vigileo (FV) against the traditional pulmonary artery catheter (PAC) in the setting of cardiothoracic surgery. [1] The authors also used echocardiography (transesophageal [TEE]/ transthoracic [TTE] ) to aid in the comparison of the aforementioned devices, which is described as the first observational study of its kind. TTE/TEE echocardiography combined with PAC is defined as the gold standard by the authors in evaluating cardiac function in postoperative cardiothoracic surgery patients, and its use in this study served as control data.
PULMONARY ARTERY CATHETER
Despite well-known limitations, the PAC has remained the gold standard for decades. It relies on invasive placement, which requires Intensive Care Unit level of care and mechanical expertise to insert and manage. Its invasiveness potentiates the risk of infections and other issues including arrhythmias, pulmonary artery rupture, and death. Though the data can sometimes be misinterpreted, the PAC remains widely used. It also remains cost-effective and can be used in a wide patient population. [2] 
FLOTRAC™/ VIGILEO
There is no debate regarding the potential benefit of the use of the FV-the debate is whether the technology is suitable for use across a patient population with diverse comorbidities and rapidly changing hemodynamics. The ability to monitor continuous cardiac output (CO) carries many advantages in aiding providers to manage and select appropriate interventions. The FV is favored because it would offset potential risks involved with a PAC. The FV is also significantly less invasive in comparison to the PAC as it uses the radial artery in this particular study, which carries a lower rate of overall complications and requirements for central venous access.
TRANSESOPHAGEAL/TRANSTHORACIC ECHOCARDIOGRAPHY
Both TTE and TEE echocardiography provide valuable information regarding cardiac function, particularly regarding cardiac contractility and valvular function. TTE echocardiography is ideally suited to assess cardiac function as it is easily and noninvasively performed at the bedside and can provide a real-time visualization of cardiac structures. While it does require some technical expertise to interpret, remote reviewing of images facilitates widespread use and many clinicians are quick to learn the basic interpretations.
TEE echocardiography is invasive and requires procedural sedation to perform. However, the TEE echocardiography is routinely used intraoperatively during coronary artery bypass grafting and valvular surgeries, and such data can provide a real-time assessment of physiology and the response to interventions.
[3]
DISCUSSION
After reviewing the data in the study, several concerns arise regarding the accuracy of the FV device. The study demonstrates how FV can be compared to the current gold standard, PAC. First, it was used only in a limited segment of the cardiac surgical population. It was not used in atrial fibrillation or in the setting of any significant valvular disorders, particularly in aortic stenosis (AS). [4] The incidence of atrial fibrillation after cardiothoracic surgery is around 31% (n = 1832), and when it occurs, hemodynamic instability is often encountered emphasizing that such technology might be least useful in times of greatest need.
[5] Significant AS is not uncommon either estimated as being found in approximately 12.4% of the elderly patient population or 3.4% having severe AS (n = 9723). [6] All these leave the FV as a relative tool in cardiac surgery patients.
In this study, the FV corresponds well with TEE/TTE echocardiography during a "normal" state, outperforming 
